{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T02:25:09Z","timestamp":1772504709104,"version":"3.50.1"},"reference-count":32,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1507\/endocrj.ej19-0262","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T22:04:27Z","timestamp":1585087467000},"page":"645-654","source":"Crossref","is-referenced-by-count":12,"title":["Comparison between the clinical characteristics of patients with adrenal incidentalomas and those with hypertension-associated adrenal tumors in a single center in Japan"],"prefix":"10.1507","volume":"67","author":[{"given":"Mari","family":"Aoe","sequence":"first","affiliation":[{"name":"Division of Nephrology and Endocrinology, the University of Tokyo Hospital, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Okada","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, the University of Tokyo Hospital, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Usui","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, the University of Tokyo Hospital, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsunori","family":"Manaka","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, the University of Tokyo Hospital, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, the University of Tokyo Hospital, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, the University of Tokyo Hospital, Tokyo 113-8655, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, et al. (2016) Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 175: G1\u2013G34.","DOI":"10.1530\/EJE-16-0467"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, et al. (2006) Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest 29: 298\u2013302.","DOI":"10.1007\/BF03344099"},{"key":"3","unstructured":"3 Ichijo T, Ueshiba H (2005) Epidemiologic study of adrenal incidentaloma in Japan, Final report. Annual Report of the Ministry of Health and Welfare \u201cDisorders of Adrenal Hormones\u201d Research Committee, Japan: 121\u2013129 (In Japanese)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"5 Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, et al. (2018) New diagnostic criteria of adrenal subclinical Cushing\u2019s syndrome: opinion from the Japan Endocrine Society. Endocr J 65: 383\u2013393.","DOI":"10.1507\/endocrj.EJ17-0456"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6 Tabuchi Y, Otsuki M, Kasayama S, Kosugi K, Hashimoto K, et al. (2016) Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan. Endocr J 63: 29\u201335.","DOI":"10.1507\/endocrj.EJ15-0404"},{"key":"6","unstructured":"7 The Japan Endocrine Society (2018) Diagnostic criteria of pheochromocytoma and paraganglioma. In: clinical practice guideline of pheochromocytoma and paraganglioma. SHINDAN TO CHIRYO SHA, Inc., Tokyo, Japan: xii (In Japanese)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"8 Rimoldi SF, Scherrer U, Messerli FH (2014) Secondary arterial hypertension: when, who, and how to screen? Eur Heart J 35: 1245\u20131254.","DOI":"10.1093\/eurheartj\/eht534"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9 Kayser SC, Dekkers T, Groenewoud HJ, van der Wilt GJ, Carel Bakx J, et al. (2016) Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis. J Clin Endocrinol Metab 101: 2826\u20132835.","DOI":"10.1210\/jc.2016-1472"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10 Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, et al. (2017) Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol 69: 1811\u20131820.","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11 Nishikawa T, Omura M (2000) Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother 54: 83s\u201385s.","DOI":"10.1016\/S0753-3322(00)80019-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193\u2013202.","DOI":"10.1291\/hypres.27.193"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13 Comlekci A, Yener S, Ertilav S, Secil M, Akinci B, et al. (2010) Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37: 40\u201346.","DOI":"10.1007\/s12020-009-9260-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14 Kim HY, Kim SG, Lee KW, Seo JA, Kim NH, et al. (2005) Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 20: 303\u2013309.","DOI":"10.3904\/kjim.2005.20.4.303"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15 Miura K, Nagai M, Ohkubo T (2013) Epidemiology of hypertension in Japan: where are we now? Circ J 77: 2226\u20132231.","DOI":"10.1253\/circj.CJ-13-0847"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16 Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, et al. (2000) A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 85: 637\u2013644.","DOI":"10.1210\/jc.85.2.637"},{"key":"16","unstructured":"17 Li L, Yang G, Zhao L, Dou J, Gu W, et al. (2017) Baseline demographic and clinical characteristics of patients with adrenal incidentaloma from a single center in China: a survey. Int J Endocrinol 2017: 3093290."},{"key":"17","doi-asserted-by":"crossref","unstructured":"18 Ahn SH, Kim JH, Baek SH, Kim H, Cho YY, et al. (2018) Characteristics of adrenal incidentalomas in a large, prospective computed tomography-based multicenter study: the COAR study in Korea. Yonsei Med J 59: 501\u2013510.","DOI":"10.3349\/ymj.2018.59.4.501"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19 Goh Z, Phillips I, Hunt PJ, Soule S, Cawood TJ (2018) Characteristics of adrenal incidentalomas in a New Zealand centre. Intern Med J 48: 173\u2013178.","DOI":"10.1111\/imj.13651"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20 Cho YY, Suh S, Joung JY, Jeong H, Je D, et al. (2013) Clinical characteristics and follow-up of Korean patients with adrenal incidentalomas. Korean J Intern Med 28: 557\u2013564.","DOI":"10.3904\/kjim.2013.28.5.557"},{"key":"20","doi-asserted-by":"crossref","unstructured":"21 Kim J, Bae KH, Choi YK, Jeong JY, Park KG, et al. (2013) Clinical characteristics for 348 patients with adrenal incidentaloma. Endocrinol Metab (Seoul) 28: 20\u201325.","DOI":"10.3803\/EnM.2013.28.1.20"},{"key":"21","doi-asserted-by":"crossref","unstructured":"22 Abe I, Sugimoto K, Miyajima T, Ide T, Minezaki M, et al. (2018) Clinical investigation of adrenal incidentalomas in Japanese patients of the Fukuoka region with updated diagnostic criteria for sub-clinical Cushing\u2019s syndrome. Intern Med 57: 2467\u20132472.","DOI":"10.2169\/internalmedicine.0550-17"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Ng VW, Ma RC, So WY, Choi KC, Kong AP, et al. (2010) Evaluation of functional and malignant adrenal incidentalomas. Arch Intern Med 170: 2017\u20132020.","DOI":"10.1001\/archinternmed.2010.441"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24 Nanba K, Tsuiki M, Sawai K, Mukai K, Nishimoto K, et al. (2013) Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry. J Clin Endocrinol Metab 98: 1567\u20131574.","DOI":"10.1210\/jc.2012-3726"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Nanba AT, Nanba K, Byrd JB, Shields JJ, Giordano TJ, et al. (2017) Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism. Clin Endocrinol (Oxf) 87: 665\u2013672.","DOI":"10.1111\/cen.13442"},{"key":"25","unstructured":"26 Yanase T (2012) Research on adrenal disorders as one of Japan intractable diseases supported by ministry of health, labour and welfare. The Medical Frontline 67: 1981\u20131988 (In Japanese)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"27 Di Dalmazi G, Pasquali R, Beuschlein F, Reincke M (2015) Subclinical hypercortisolism: a state, a syndrome, or a disease? Eur J Endocrinol 173: M61\u2013M71.","DOI":"10.1530\/EJE-15-0272"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28 Di Dalmazi G, Vicennati V, Garelli S, Casadio E, Rinaldi E, et al. (2014) Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study. Lancet Diabetes Endocrinol 2: 396\u2013405.","DOI":"10.1016\/S2213-8587(13)70211-0"},{"key":"28","unstructured":"29 Fujimoto K, Honjo S, Tatsuoka H, Hamamoto Y, Kawasaki Y, et al. (2013) Primary aldosteronism associated with subclinical Cushing syndrome. J Endocrinol Invest 36: 564\u2013567."},{"key":"29","doi-asserted-by":"crossref","unstructured":"30 Hiraishi K, Yoshimoto T, Tsuchiya K, Minami I, Doi M, et al. (2011) Clinicopathological features of primary aldosteronism associated with subclinical Cushing\u2019s syndrome. Endocr J 58: 543\u2013551.","DOI":"10.1507\/endocrj.K10E-402"},{"key":"30","doi-asserted-by":"crossref","unstructured":"31 Piaditis GP, Kaltsas GA, Androulakis II, Gouli A, Makras P, et al. (2009) High prevalence of autonomous cortisol and aldosterone secretion from adrenal adenomas. Clin Endocrinol (Oxf) 71: 772\u2013778.","DOI":"10.1111\/j.1365-2265.2009.03551.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32 Hao M, Lopez D, Luque-Fernandez MA, Cote K, Newfield J, et al. (2018) The lateralizing asymmetry of adrenal adenomas. J Endocr Soc 2: 374\u2013385.","DOI":"10.1210\/js.2018-00034"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33 Dietrich CF, Wehrmann T, Hoffmann C, Herrmann G, Caspary WF, et al. (1997) Detection of the adrenal glands by endoscopic or transabdominal ultrasound. Endoscopy 29: 859\u2013864.","DOI":"10.1055\/s-2007-1004322"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/6\/67_EJ19-0262\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T03:43:02Z","timestamp":1593834182000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/67\/6\/67_EJ19-0262\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej19-0262","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}